Journal article : Review
The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria
- Abstract:
- Estimating the contribution of antimicrobial resistance (AMR) to global mortality and healthcare costs enables evaluation of interventions, informs policy decisions on resource allocation, and drives research priorities. However assembling the high quality, patient-level data required for global estimates is challenging. Capacity for accurate microbiology culture and antimicrobial susceptibility testing is woefully neglected in low and middle-income countries, and further surveillance and research on community antimicrobial usage, bias in blood culture sampling, and the contribution of co-morbidities such as diabetes is essential. International collaboration between governments, policy makers, academics, microbiologists, front-line clinicians, veterinarians, the food and agriculture industry and the public is critical to understand and tackle AMR.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 466.4KB, Terms of use)
-
- Publisher copy:
- 10.1016/j.mib.2020.09.013
Authors
- Publisher:
- Elsevier
- Journal:
- Current Opinion in Microbiology More from this journal
- Volume:
- 57
- Issue:
- October 2020
- Pages:
- 95-101
- Publication date:
- 2020-11-02
- Acceptance date:
- 2020-09-23
- DOI:
- EISSN:
-
1879-0364
- ISSN:
-
1369-5274
- Pmid:
-
33147565
- Language:
-
English
- Keywords:
- Subtype:
-
Review
- Pubs id:
-
1141031
- Local pid:
-
pubs:1141031
- Deposit date:
-
2020-11-20
- ARK identifier:
Terms of use
- Copyright holder:
- S Dunachie et al.
- Copyright date:
- 2020
- Rights statement:
- © 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4.0/).
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record